Structural Formula (Acy03 0000 01)
Acyclovir Capsule
Product Images NDC 71335-1290
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 71335-1290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 1 (Acy03 0000 02)
Table 1 shows various pharmacokinetic characteristics of Acyclovir, an antiviral medication. The table includes the range of plasma protein binding capacity, plasma elimination half-life, and average oral bioavailability. The plasma protein binding range is between 9% and 1033%, while the plasma elimination half-life is between 25 and 1033 hours. The average oral bioavailability ranges from 10% to 20%, with a decrease in bioavailability with increasing dose.*
Table 2 (Acy03 0000 03)
This is a table presenting the acyclovir peak and trough concentrations at steady state for three different doses (200mg, 400mg, and 800mg). The table includes two parameters, Coax and C_irough, both measured in meg/mL.*
Table 3 (Acy03 0000 04)
This is a table that provides Dosage Modification for Renal Impairment. The table shows the Normal Dosage, Creatinine Clearance, and Adjusted Dosage Regimen. The dosage is adjusted based on the Creatinine Clearance (mL/min/1.73 m2) and Dosing Interval. The table provides specific dosages for different levels of Creatinine Clearance, ranging from > 25 mL/min/1.73 m2 to 0-10 mL/min/1.73 m2. The adjusted dosages range from 200mg every 4 hours to 800mg every 12 hours.*
Label Image (Lbl713351290)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
